Clinical Observation on Adjuvant Therapy of Danhong Injection(丹红注射液) Combined with Shenmai Injection(参麦注射液) in the Treatment of 45 Cases of Chronic Heart Failure with Qi and Yin Deficiency Type
|更新时间:2021-11-17
|
Clinical Observation on Adjuvant Therapy of Danhong Injection(丹红注射液) Combined with Shenmai Injection(参麦注射液) in the Treatment of 45 Cases of Chronic Heart Failure with Qi and Yin Deficiency Type
Journal of Traditional Chinese MedicineVol. 56, Issue 22, Pages: 1942-1945(2015)
LI Wei, REN Jiansu, NI Huijun. Clinical Observation on Adjuvant Therapy of Danhong Injection(丹红注射液) Combined with Shenmai Injection(参麦注射液) in the Treatment of 45 Cases of Chronic Heart Failure with Qi and Yin Deficiency Type[J]. Journal of Traditional Chinese Medicine2015, 56(22): 1942-1945.
LI Wei, REN Jiansu, NI Huijun. Clinical Observation on Adjuvant Therapy of Danhong Injection(丹红注射液) Combined with Shenmai Injection(参麦注射液) in the Treatment of 45 Cases of Chronic Heart Failure with Qi and Yin Deficiency Type[J]. Journal of Traditional Chinese Medicine2015, 56(22): 1942-1945.DOI: 10.13288/j.11-2166/r.2015.22.015.
Clinical Observation on Adjuvant Therapy of Danhong Injection(丹红注射液) Combined with Shenmai Injection(参麦注射液) in the Treatment of 45 Cases of Chronic Heart Failure with Qi and Yin Deficiency Type
Objective To explore the clinical curative effect of adjuvant therapy of Danhong Injection combined with Shenmai Injection in the treatment of chronic heart failure with Qi and yin deficiency. Methods Ninety patients with chronic heart failure with Qi and yin deficiency were randomly divided into a treatment group and a control group
with 45 cases in each group. The control group was treated with 60 ml of Shenmai Injection in 200 ml of normal saline by intravenous drip
once daily
combined with conventional western medicine treatment; On the basis of the treatment for the control group
the treatment group was added with 20 ml of Danhong Injection in 250 ml of 5%glucose injection by intravenous drip once daily. The course of treatment was 2 weeks for both groups. The following index of patients in two groups were compared: the New York Heart Association( NYHA) Functional Classification
the total score of heart failure and TCM syndrome
six minutes walking distance
serum level of amino terminal brain natriuretic peptide( NT-pro BNP)
and ultrasonic echocardiography index. Results The total effective rate of NYHA function classification was 97. 78% in the treatment group
and 91. 11% in the control group
with no statistically significant difference between the two groups( P>0. 05). After treatment in both groups
the total score of heart failure and TCM Syndrome were significantly lower than those before treatment
left ventricular ejection fraction( LVEF)
stroke volume( SV)
and cardiac output( CO) were improved
and six minutes walking distance increased( P<0. 05). After treatment
the total score of heart failure and TCM Syndrome in treatment group was lower than that in control group
and the six minute walk distance
as well as levels of LVEF
SV and CO were higher than those in control group( P<0. 05). After treatment and during the 2 months of follow-up
the serum level of NT-pro BNP in both groups were significantly decreased compared with that before treatment( P<0. 05). After treatment and during the 2 months of follow-up
the serum level of NT-pro BNP in the treatment group was significantly lower than that in the control group( P<0. 05). Conclusion Adjuvant therapy of Danhong Injection combined with Shenmai Injection can significantly improve the clinical symptoms of the chronic heart failure patients with Qi Yin deficiency type
increase the six minutes walking distance
reduce the levels of NT-pro BNP and improve heart function.
Effect of Shenqi Jianxin Formula(参芪健心方)on Mitochondrial Autophagy and the PINK1/Parkin Signaling Pathway in Cardiac Tissues in Chronic Heart Failure
Effect of Optimized New Shengmai Powder (优化新生脉散方) on Exercise Tolerance in Patients with Chronic Heart Failure of Qi Deficiency,Blood Stasis and Fluid Retention Syndrome:A Randomized,Double-Blind,Placebo-Controlled Trial
Overview of Study on Syndromic Characteristics and Microscopic Indicators of Qi Deficiency and Blood Stasis Syndrome in Chronic Heart Failure
Effect of Shenfu Injection (参附注射液) on SIRT1 Deacetylation-modified Regulation of HMGB1/TLR4/NF-κB Pathway in Isoproterenol-induced Cardiomyocyte Injury Model
Bushen Huoxue Formula (补肾活血方) Combined with Conventional Western Medicine for 129 Patients of Heart Failure with Mid-range Ejection Fraction with Syndrome of Qi Deficiency and Blood Stasis:A Randomized Controlled Trial
Related Author
XIE Peichi
LIU Pan
DING Zitong
BAI Jingyi
PANG Deqi
DAI Xiaohua
WANG Xianliang
ZHANG Jingyi
Related Institution
First Clinical Medical College,Anhui University of Chinese Medicine
College of Traditional Chinese Medicine,Anhui University of Chinese Medicine
The First Affiliated Hospital of Anhui University of Chinese Medicine
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/ National Clinical Research Center for Chinese Medicine
Tianjin University of Traditional Chinese Medicine